Whole Genome And Exome Sequencing Market Poised for 24.9 % Growth, Set to Hit $2 Billion by 2029

How Are the key drivers contributing to the expansion of the whole genome and exome sequencing market?
The upsurge in demand for personalized medicine is depicted as a catalyst for the expansion of the whole genome and exome sequencing market in the foreseeable future. This is because the concept of personalized medicine revolves around strategies for healthcare decisions and interventions, personalized per patient, considering factors of genetics, environment, and lifestyle. The technique of whole genome and exome sequencing plays a vital role in personalized medicine, offering a complete analysis of a person's genetic constitution, enabling healthcare decisions and interventions to be made as per their distinct genetic, environmental, and lifestyle characteristics. For example, the Personalized Medicine Coalition (PMC), an organization in the US that encourages the understanding and adoption of personalized medicine, forecasted that around 75,000 genetic testing products and 300 personalized medicines will comprise the market in 2022, as of October 2022. In addition, the approval by the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) for 37 new molecular entities (NMEs) in 2022, with nearly 34% of the 35 therapeutic NMEs, about 12 of them, classified as personalized, underlines the growing application of personalized medicine. As such, this growing demand is driving the surge in growth of the whole genome and exome sequencing market.

Get Your Whole Genome And Exome Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

What growth opportunities are expected to drive the whole genome and exome sequencing market's CAGR through 2034?
The market size of full genome and exome sequencing has seen a substantial increase in the past few years. The market valuation is set to expand from $2.02 billion in 2024 to $2.53 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 24.8%. The significant growth observed in the past years can be credited to factors such as the declining costs of sequencing, the escalating prevalence of genetic disorders, the applicability in clinical fields, the growth of genomic data storage, and the development in bioinformatics.

The market size for whole genome and exome sequencing is set to experience significant expansion in the coming years. Projections suggest that it will expand to reach $6.14 billion in 2029, showing a compound annual growth rate (CAGR) of 24.9%. A series of factors are anticipated to drive this growth during the forecast period, including population genomics initiatives, growing demand for precision medicine, advances in single-cell sequencing, expansion of non-invasive prenatal testing (NIPT) and its application in research of rare diseases. Key trends visible in the projection period involve increased clinical adoption, swift progress in sequencing technologies, the emergence of population-scale genomic studies, integration of AI and machine learning, and wider applications in oncology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What are the emerging trends shaping the future of the whole genome and exome sequencing market?
Prominent firms in the whole genome and exome sequencing markets are focusing on introducing cutting-edge technological solutions, such as ultra-rapid next-generation sequencing (NGS) analysis, to maintain their competitive edge. Ultra-rapid NGS analysis is a tech breakthrough that facilitates the processing of NGS data at a remarkably speedy rate, greatly diminishing the time needed to analyze genomic data. For example, in January 2023, US-based bioinformatics firm QIAGEN Digital Insights (QDI) introduced an ultra-rapid NGS analysis platform. Said platform provides features like tackling a whole genome in 25 minutes at the cost of $1 in cloud computing, highlighting efficiency, cost-effectiveness, and scalability. Its innovative technology significantly bolsters the speed and availability of genomic data analysis, playing a crucial role in the whole genome and exome sequencing market by facilitating quick decision-making and broader implementation of personalized medicine.

Which growth-oriented segments of the whole genome and exome sequencing market are leading the industry's development?
The whole genome and exome sequencing market covered in this report is segmented -

1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the whole genome and exome sequencing market?
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

What Is Covered In The Whole Genome And Exome Sequencing Global Market Report?

•Market Size Forecast: Examine the whole genome and exome sequencing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the whole genome and exome sequencing market for a structured understanding.
•Key Players Overview: Analyze major players in the whole genome and exome sequencing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the whole genome and exome sequencing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the whole genome and exome sequencing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the whole genome and exome sequencing market.
•Industry Challenges: Identify potential risks and obstacles affecting the whole genome and exome sequencing market.
•Competitive Landscape: Review strategic developments in the whole genome and exome sequencing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.